Articles

A national strategy focused on digital health, nutrition, and other high-impact interventions has dramatically improved health outcomes across India—but more work remains to be done.

One of the earliest and most dangerous health threats young infants face is one many parents have never even heard of: Group B Streptococcus (GBS). One researcher gives his take on why we need a vaccine.

New rapid diagnostic tests for onchocerciasis (river blindness) and lymphatic filariasis will guide surveillance of mass drug administration programs needed for elimination.

A new resource sheds light on what’s needed to get ready for a new vaccine that, if approved, could help pregnant mothers protect their babies from a common cause of serious respiratory infections—respiratory syncytial virus.